184 reports of this reaction
1.5% of all LUMACAFTOR AND IVACAFTOR reports
#15 most reported adverse reaction
INFLUENZA is the #15 most commonly reported adverse reaction for LUMACAFTOR AND IVACAFTOR, manufactured by Vertex Pharmaceuticals Incorporated. There are 184 FDA adverse event reports linking LUMACAFTOR AND IVACAFTOR to INFLUENZA. This represents approximately 1.5% of all 12,020 adverse event reports for this drug.
Patients taking LUMACAFTOR AND IVACAFTOR who experience influenza should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INFLUENZA is a less commonly reported adverse event for LUMACAFTOR AND IVACAFTOR, but still significant enough to appear in the safety profile.
In addition to influenza, the following adverse reactions have been reported for LUMACAFTOR AND IVACAFTOR:
The following drugs have also been linked to influenza in FDA adverse event reports:
INFLUENZA has been reported as an adverse event in 184 FDA reports for LUMACAFTOR AND IVACAFTOR. This does not prove causation, but indicates an association observed in post-market surveillance data.
INFLUENZA accounts for approximately 1.5% of all adverse event reports for LUMACAFTOR AND IVACAFTOR, making it a notable side effect.
If you experience influenza while taking LUMACAFTOR AND IVACAFTOR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.